Travel Medicine Advisor Archives – April 1, 2006
April 1, 2006
View Archives Issues
-
Rifaximin For Gastrointestinal Disorders
Potential new uses of rifaximin are examined in a recent CID article by Adachi and DuPont. Rifaximin, a semisynthetic derivative of rifamycin, received FDA approval in May of 2004, for the treatment of travelers diarrhea in patients 12 years of age and older caused by non-invasive strains of E. coli. -
Food and Water Safety: Geographic Variations
In June 1998, there were numerous reports of diarrheal illness in multiple attendees of events catered by a delicatessen in Chicago, Illinois. -
Fevers Along the Thai-Myanmar Border
Collaborators from the Armed Forces Research Institute for Medical Sciences (AFRIMS) and the Kwai River Christian Hospital assessed the causes of febrile illness in the adult population in Sangkhlaburi, Thailand, near the border with Myanmar. -
Management of Occupational Exposures to HIV
Exposure of healthcare personnel to either blood or the bloody secretions of an HIV-seropositive person has only occasionally resulted in HIV infection. -
Pharmacology Watch: Can Calcium and Vitamin D Prevent Hip Fractures?
Treatment of Benign Prostatic Hyperplasia; Treatment of Osteoarthritis of the Knee; Refractory Asthma and TNFConnection?; FDA Actions